Tech Company Financing Transactions
Mimetogen Pharmaceuticals Funding Round
Mimetogen Pharmaceuticals closed a $400 thousand investment round on 7/22/2013. Backers included Medwell Capital.
Transaction Overview
Company Name
Announced On
7/22/2013
Transaction Type
Venture Equity
Amount
$400,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
67 Batterymarch St. 5th Floor
Boston, MA 02110
USA
Boston, MA 02110
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Mimetogen Pharmaceuticals is a venture-backed biotechnology company founded by Prof. H. Uri Saragovi and Dr. Garth Cumberlidge. The company is actively pursuing the development of novel small molecule compounds to treat neurodegenerative diseases of the eye, including dry eye, glaucoma and retinitis pigmentosa.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
François Mongrain
VP - Bus. Development
Karen Meerovitch
Browse more venture capital transactions:
Prev: 7/22/2013: Livio Radio venture capital transaction
Next: 7/23/2013: InMage Systems venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs